Skip to content

About

Built for the long arc of drug development.

Avidia Pharma Labs LLP specialises in oral dosage forms and injectable formulations, supporting clients from concept through regulatory filing with integrated CRO + CDMO services.

Who we are

A full-fledged R&D + CDMO partner.

Avidia Pharma Labs LLP specialises in oral dosage forms and injectable formulations, supporting clients from concept through regulatory filing with integrated CRO + CDMO services.

Our portfolio serves the US, Europe, and ROW markets — spanning cardiovascular, anticancer, antidiabetic, neurology, antibiotics and more.

Oral Dosage Forms

IR, SR, CR, enteric-coated tablets & capsules, solutions, suspensions, and syrups.

Injectables

Solutions, suspensions, lyophilized products, and peptides — including oncology injectables.

Therapeutic categories

CardiovascularAnticancerAntidiabeticNeurologyAntibiotics+ more

Vision

Science-led partnership that takes molecules from concept to commercial supply — dependably.

Mission

Integrated R&D and CDMO capability — rigorous, regulation-ready, and built for global submissions.

Core pillars

Five foundations that define who we are.

01

Scientific Excellence

QbD-driven R&D by experienced scientists pushing pharma innovation boundaries.

02

Uncompromising Quality

GMP/cGMP and ICH-compliant, audit-ready at every development stage.

03

Regulatory Mastery

Deep US FDA & EU EMA expertise ensuring smooth global submissions.

04

Relentless Innovation

Novel formulations, 505(b)(2) and oncology programs driven by bold IP creation.

05

Client Partnership

Transparent, tailored collaboration — from startup to global pharma leader.

Leadership

The team behind the work.

Leadership bios coming soon.

Get in touch

Let's build something dependable together.

Whether it's an early-stage formulation challenge, a 505(b)(2) program, or a commercial tech transfer — we'd be glad to talk through how we can help.